RT @NicholasZaorsky: Radiotherapy logistics are important, especially in the time of COVID. @jamesbyu @seanmmcbride @rtdess @BrandonMahal…
Radiotherapy logistics are important, especially in the time of COVID. @jamesbyu @seanmmcbride @rtdess @BrandonMahal @achoud72 @alison_tree @DrSpratticus https://t.co/iC0FnAuBAg https://t.co/u9Tns7RC2m
Short-course radiation therapy is especially important during COVID https://t.co/B3ihToZIKf https://t.co/VUxGfPKrB9 @jamesbyu @seanmmcbride @rtdess @BrandonMahal @achoud72 @alison_tree @DrSpratticus
During the pandemic, if radiation treatment for #prostatecancer is harder to access, hormone therapy can buy up to 6 months before radiation. https://t.co/cIMHJbzx4s
RT @NicholasZaorsky: Also, during #COVID__19, more men can receive treatment while avoiding virus. https://t.co/VUxGfPKrB9 @jamesbyu @sean…
Also, during #COVID__19, more men can receive treatment while avoiding virus. https://t.co/VUxGfPKrB9 @jamesbyu @seanmmcbride @rtdess @BrandonMahal @achoud72 @alison_tree @DrSpratticus https://t.co/8uEmVsk4Zi
💡Send @evicorehc the multi-institutional #COVID prostate RT guidelines specifying that ultra-hypofrac is *PREFERRED*: https://t.co/YOfek6ADNU 👏@DrSpratticus @jamesbyu @seanmmcbride @NicholasZaorsky #pcsm #radonc
CCC publication: Prostate Cancer Radiotherapy Recommendations in Response to COVID-19 https://t.co/Am7UPNzMQ9 #research #healthresearch #openaccess #covid19 @CCC_Staff
"Prostate Cancer Radiotherapy Recommendations in Response to COVID-19" via #AdvancesInRadiationOncology @ASTRO_org #RadOnc https://t.co/Ow0fRNzThd
Prostate Cancer Radiotherapy Recommendations in Response to #COVID19. 𝘼𝙙𝙫 𝙍𝙖𝙙𝙞𝙖𝙩 𝙊𝙣𝙘𝙤𝙡. @DrSpratticus #ProstateCancer https://t.co/qJ7JLh7afq
Advances in Radiation Oncology: Prostate Cancer Radiotherapy Recommendations in Response to COVID-19 https://t.co/hQeqYn7WLN
RT @UctCri: This paper discusses the new RADS (Remote visits, and Avoidance, Deferment, and Shortening of radiotherapy) framework that was…
This paper discusses the new RADS (Remote visits, and Avoidance, Deferment, and Shortening of radiotherapy) framework that was developed to ensure optimal management of prostate cancer patients during the COVID-19 pandemic. https://t.co/JRZCeDELqI